|
|
Article: Advanced Viral Research Corp. Announces Research Agreement With The Weizmann Institute Of Science.
- Article from:
- PR Newswire
- Article date:
- February 1, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Scientists at Weizmann Institute of Science to Study Company's
Flagship,Broad-Spectrum Immunomodulator, Product R -
YONKERS, N.Y., Feb. 1 /PRNewswire/ --
Shalom Z. Hirschman, M.D., President and C.E.O. of Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), today announced a research agreement with the world-renowned Weizmann Institute of Science and with YEDA, its developmental arm, both located in Rehovot, Israel, to study the immunological effects of Product R, Advanced Viral Research Corp.'s flagship immunomodulator and antiviral drug.
Scientists in the Department of Immunology at The Weizmann Institute of Science, under the ...